ArticleBMC cancer2017

Appraising the holistic value of Lenvatinib for radio-iodine refractory differentiated thyroid cancer: A multi-country study applying pragmatic MCDA.

Monika Wagner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.